Pelareorep combined with modified FOLFIRINOX, with or without Tecentriq, shows an acceptable safety profile in metastatic PDAC patients. All patients experienced side effects, with some severe cases, ...
Preclinical development of the lipid nanoparticle–based mRNA vaccine with multiple natural T cell epitopes for pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback